Background
Breast cancer, cancers, breast cancer
BREAST CANCER, RECURRENCE, CANCERS, BREAST CANCER
Breast cancer ranks among the most frequently detected cancers in women globally, with an approximate occurrence of 2.3 million new cases [Estrogen is an important factor in breast cancer development and prognosis. In primary treatments of breast cancer, luteinizing hormone-releasing hormone agonist (LHRHa) can be used to reduce estrogen levels in patients with positive hormone receptors [The TEXT-SOFT trial showed that the combination of aromatase inhibitors such as Exemestane with ovarian inhibitors significantly reduces the chance of recurrence compared to Tamoxifen plus ovarian inhibitors [Triptorelin is a GnRH analog which initially stimulates the pituitary gland. After continuous contact with its receptor, triptorelin can inhibit gonadotropin release by reducing the sensitivity or reducing the production of receptors [